Description

6-[[4-[2-[4-(1,1-Dimethylethyl)Phenyl]-1H-Benzimidazol-7-Yl]-I-Piperazinyl]Methyl]-Quinoxalinedihydrochloride is a high-purity, non-peptidic small molecule compound of significant interest in advanced pharmaceutical research and development. Its complex heterocyclic structure, featuring benzimidazole and quinoxaline moieties, makes it a valuable intermediate for creating novel therapeutic agents. This compound is primarily utilized by research institutions and pharmaceutical companies engaged in the discovery of new drugs targeting complex biological pathways.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, particularly in oncology and neurology research.
• Biochemical Research: Used as a reference standard or a tool compound in enzymatic and receptor-binding assays to study specific biological interactions.
• Medicinal Chemistry: Acts as a core scaffold for structure-activity relationship (SAR) studies to optimize potency, selectivity, and pharmacokinetic properties of lead molecules.
• High-Throughput Screening (HTS): Employed in compound libraries for screening against novel biological targets to identify potential hits for further development.
• Chemical Biology: Utilized in probe development to investigate and modulate specific cellular functions and signaling pathways.

Basic Information

Product Name	6-[[4-[2-[4-(1,1-Dimethylethyl)Phenyl]-1H-Benzimidazol-7-Yl]-I-Piperazinyl]Methyl]-Quinoxalinedihydrochloride
CAS No.	872002-73-8
Molecular Formula	C30H33Cl2N7
Molecular Weight	562.53 g/mol
Synonyms	6-[[4-[2-[4-(tert-Butyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]methyl]quinoxaline dihydrochloride; 6-((4-(2-(4-(tert-Butyl)phenyl)-1H-benzo[d]imidazol-7-yl)piperazin-1-yl)methyl)quinoxaline dihydrochloride; UNII-0K2J8T9Q6F; 0K2J8T9Q6F; Quinoxaline, 6-[[4-[2-[4-(1,1-dimethylethyl)phenyl]-1H-benzimidazol-7-yl]-1-piperazinyl]methyl]-, dihydrochloride; BDBM50164957; HY-101196
EINECS	Contact for details

Quality Control

Our 6-[[4-[2-[4-(1,1-Dimethylethyl)Phenyl]-1H-Benzimidazol-7-Yl]-I-Piperazinyl]Methyl]-Quinoxalinedihydrochloride is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for research applications. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and analytical results is provided with every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This compound is hygroscopic (moisture-sensitive) and should be handled in a dry environment to prevent degradation. For long-term storage, consider desiccated conditions.

Specification

Item	Specification
Appearance	Off-white to light yellow solid
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.5%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.